Literature DB >> 24786789

Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase.

Yanping Xu1, Fulong Li1, Lei Lv2, Tingting Li1, Xin Zhou1, Chu-Xia Deng3, Kun-Liang Guan4, Qun-Ying Lei5, Yue Xiong6.   

Abstract

Glycolytic enzyme phosphoglycerate mutase (PGAM) plays an important role in coordinating energy production with generation of reducing power and the biosynthesis of nucleotide precursors and amino acids. Inhibition of PGAM by small RNAi or small molecule attenuates cell proliferation and tumor growth. PGAM activity is commonly upregulated in tumor cells, but how PGAM activity is regulated in vivo remains poorly understood. Here we report that PGAM is acetylated at lysine 100 (K100), an active site residue that is invariably conserved from bacteria, to yeast, plant, and mammals. K100 acetylation is detected in fly, mouse, and human cells and in multiple tissues and decreases PGAM2 activity. The cytosolic protein deacetylase sirtuin 2 (SIRT2) deacetylates and activates PGAM2. Increased levels of reactive oxygen species stimulate PGAM2 deacetylation and activity by promoting its interaction with SIRT2. Substitution of endogenous PGAM2 with an acetylation mimetic mutant K100Q reduces cellular NADPH production and inhibits cell proliferation and tumor growth. These results reveal a mechanism of PGAM2 regulation and NADPH homeostasis in response to oxidative stress that impacts cell proliferation and tumor growth. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786789      PMCID: PMC4303242          DOI: 10.1158/0008-5472.CAN-13-3615

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.

Authors:  Sung Chan Kim; Robert Sprung; Yue Chen; Yingda Xu; Haydn Ball; Jimin Pei; Tzuling Cheng; Yoonjung Kho; Hao Xiao; Lin Xiao; Nick V Grishin; Michael White; Xiang-Jiao Yang; Yingming Zhao
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

3.  Genetically encoding N(epsilon)-acetyllysine in recombinant proteins.

Authors:  Heinz Neumann; Sew Y Peak-Chew; Jason W Chin
Journal:  Nat Chem Biol       Date:  2008-02-17       Impact factor: 15.040

4.  Crystal structure of human B-type phosphoglycerate mutase bound with citrate.

Authors:  Yanli Wang; Zhiyi Wei; Lin Liu; Zhongjun Cheng; Yajing Lin; Fengyuan Ji; Weimin Gong
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

5.  Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.

Authors:  José L Avalos; Katherine M Bever; Cynthia Wolberger
Journal:  Mol Cell       Date:  2005-03-18       Impact factor: 17.970

6.  The 2.3 A X-ray crystal structure of S. cerevisiae phosphoglycerate mutase.

Authors:  D J Rigden; D Alexeev; S E Phillips; L A Fothergill-Gilmore
Journal:  J Mol Biol       Date:  1998-02-20       Impact factor: 5.469

Review 7.  Tumor cell metabolism: cancer's Achilles' heel.

Authors:  Guido Kroemer; Jacques Pouyssegur
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

8.  HIF-dependent antitumorigenic effect of antioxidants in vivo.

Authors:  Ping Gao; Huafeng Zhang; Ramani Dinavahi; Feng Li; Yan Xiang; Venu Raman; Zaver M Bhujwalla; Dean W Felsher; Linzhao Cheng; Jonathan Pevsner; Linda A Lee; Gregg L Semenza; Chi V Dang
Journal:  Cancer Cell       Date:  2007-09       Impact factor: 31.743

9.  Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.

Authors:  E Lara; A Mai; V Calvanese; L Altucci; P Lopez-Nieva; M L Martinez-Chantar; M Varela-Rey; D Rotili; A Nebbioso; S Ropero; G Montoya; J Oyarzabal; S Velasco; M Serrano; M Witt; A Villar-Garea; A Imhof; A Inhof; J M Mato; M Esteller; M F Fraga
Journal:  Oncogene       Date:  2008-12-08       Impact factor: 9.867

Review 10.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

View more
  46 in total

Review 1.  Sirtuins and the Metabolic Hurdles in Cancer.

Authors:  Natalie J German; Marcia C Haigis
Journal:  Curr Biol       Date:  2015-06-29       Impact factor: 10.834

Review 2.  Dysregulated glycolysis as an oncogenic event.

Authors:  Takumi Mikawa; Matilde E LLeonart; Akifumi Takaori-Kondo; Nobuya Inagaki; Masayuki Yokode; Hiroshi Kondoh
Journal:  Cell Mol Life Sci       Date:  2015-01-22       Impact factor: 9.261

3.  Identification of a multienzyme complex for glucose metabolism in living cells.

Authors:  Casey L Kohnhorst; Minjoung Kyoung; Miji Jeon; Danielle L Schmitt; Erin L Kennedy; Julio Ramirez; Syrena M Bracey; Bao Tran Luu; Sarah J Russell; Songon An
Journal:  J Biol Chem       Date:  2017-04-19       Impact factor: 5.157

4.  SIRT2 plays a significant role in maintaining the survival and energy metabolism of PIEC endothelial cells.

Authors:  Jie Zhang; Caixia Wang; Hui Nie; Danhong Wu; Weihai Ying
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-09-30

5.  Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage.

Authors:  Xuanye Cao; Chaoqun Li; Siyu Xiao; Yunlan Tang; Jing Huang; Shuan Zhao; Xueyu Li; Jixi Li; Ruilin Zhang; Wei Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

6.  Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer.

Authors:  Wenjing Ma; Xiaoping Zhao; Kaiying Wang; Jianjun Liu; Gang Huang
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

Review 7.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

8.  Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis.

Authors:  Young Cha; Min-Joon Han; Hyuk-Jin Cha; Janet Zoldan; Alison Burkart; Jin Hyuk Jung; Yongwoo Jang; Chun-Hyung Kim; Ho-Chang Jeong; Byung-Gyu Kim; Robert Langer; C Ronald Kahn; Leonard Guarente; Kwang-Soo Kim
Journal:  Nat Cell Biol       Date:  2017-04-24       Impact factor: 28.824

Review 9.  Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.

Authors:  Zhaoyong Li; Huafeng Zhang
Journal:  Cell Mol Life Sci       Date:  2015-10-23       Impact factor: 9.261

10.  Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.

Authors:  Arthur J Liu; Shivanand Pudakalakatti; Ashvin R Jaiswal; Prasanta Dutta; Priyamvada Jayaprakash; Todd Bartkowiak; Casey R Ager; Zhi-Qiang Wang; Alexandre Reuben; Zachary A Cooper; Cristina Ivan; Zhenlin Ju; Felix Nwajei; Jing Wang; Michael A Davies; R Eric Davis; Jennifer A Wargo; Pratip K Bhattacharya; David S Hong; Michael A Curran
Journal:  Cancer Immunol Res       Date:  2020-09-11       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.